- GDPR and its major components related to enterprises
- Its impact on pharmacovigilance-related activities – applicability, consent, data subject rights, PV data entry into the database, processing of PV data, data transfer to international organizations, data security, and the Data Protection Officer
- ArisGlobal’s approach towards GDPR-related compliance – explained across multiple areas and providing our position for how companies can achieve compliance at the level of product, process and people
PMI Life Sciences Goes Live with LifeSphere Safety to Modernize Global Safety Surveillance
Two LifeSphere Safety products–MultiVigilance and Reporting and Analytics–are powering PMI’s pharmacovigilance efficiencies in multiple languages with automation and machine learning. MIAMI, FL — June 16, 2022 — ArisGlobal, the leading provider of life sciences...